Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandeep Kaur Brar
Observed names:
S. Brar,
Sandeep Brar
Institution:
Medtronic (United States)
Observed institutions:
Brigham and Women's Hospital,
Jichi Medical University,
Guru Nanak Dev University,
University of Chicago,
University of Chicago Medical Center,
Medtronic (United States),
University of Pennsylvania
show all 7
ORCID:
0000-0003-3429-0061
Observed ORCID:
0000-0003-3429-0061
OpenAlex ID:
A5103247969
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
2018
·
David E Kandzari
, Michael Böhm
, et al.
·
The Lancet
·
811
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
2020
·
Michael Böhm
, Kazuomi Kario
, et al.
·
The Lancet
·
629
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
2014
·
D. E. Kandzari
, D. L. Bhatt
, et al.
·
European Heart Journal
·
553
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
2022
·
Felix Mahfoud
, David E Kandzari
, et al.
·
The Lancet
·
314
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
2022
·
Deepak L Bhatt
, Muthiah Vaduganathan
, et al.
·
The Lancet
·
191
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
2023
·
David E. Kandzari
, Raymond R. Townsend
, et al.
·
Journal of the American College of Cardiology
·
130
12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension
2015
·
George L. Bakris
, Raymond R. Townsend
, et al.
·
Journal of the American College of Cardiology
·
108
PDF
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –
2016
·
Kazuomi Kario
, Deepak L. Bhatt
, et al.
·
Circulation Journal
·
84
PDF
Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
2022
·
Kazuomi Kario
, Felix Mahfoud
, et al.
·
Hypertension Research
·
59
PDF
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
2017
·
Matthew J. Price
, Shigeru Saito
, et al.
·
JACC: Cardiovascular Interventions
·
57
PDF
Regression to the Mean in SYMPLICITY HTN-3
2016
·
Stuart J. Pocock
, George Bakris
, et al.
·
Journal of the American College of Cardiology
·
53
PDF
Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure
2015
·
Kazuomi Kario
, Deepak L. Bhatt
, et al.
·
Hypertension
·
49
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent
2017
·
Stephen G. Worthley
, Alexandre Abizaid
, et al.
·
JACC: Cardiovascular Interventions
·
44
PDF
Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
2020
·
Michael Böhm
, Raymond R. Townsend
, et al.
·
Clinical Research in Cardiology
·
42
PDF
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
2024
·
Raymond R. Townsend
, Keith C. Ferdinand
, et al.
·
Hypertension
·
37
PDF
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial
2015
·
John M. Flack
, Deepak L. Bhatt
, et al.
·
Journal of the American Society of Hypertension
·
36
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy
2019
·
Elvin Kedhi
, Azeem Latib
, et al.
·
American Heart Journal
·
35
PDF
Differences in Dynamic Diurnal Blood Pressure Variability Between Japanese and American Treatment-Resistant Hypertensive Populations
2017
·
Kazuomi Kario
, Deepak L. Bhatt
, et al.
·
Circulation Journal
·
32
PDF
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
2025
·
David E. Kandzari
, Felix Mahfoud
, et al.
·
Circulation Cardiovascular Interventions
·
25
Rationale and design of the prevail global trial program evaluating the prevail drug-coated balloon in patients with in-stent restenosis and de novo small vessel disease
2025
·
David E. Kandzari
, Azeem Latib
, et al.
·
American Heart Journal
·
8
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
2021
·
Michael Böhm
, Martin Fahy
, et al.
·
Contemporary Clinical Trials Communications
·
8
PDF
Age Specific Relation of Blood Pressure with Anthropometric Variables among 19-24 years Punjabi Female Youth of Amritsar City in Punjab, India
2009
·
Badaruddoza Brar
, Amandeep Brar
, et al.
·
The Anthropologist
·
6
Three‐Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN‐ON MED
2026
·
David E. Kandzari
, Felix Mahfoud
, et al.
·
Journal of the American Heart Association
·
3
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts
2016
·
Robert W. Harrison
, Vaishnavi Radhakrishnan
, et al.
·
American Heart Journal
·
3
The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts
2018
·
Robert W. Harrison
, Vaishnavi Radhakrishnan
, et al.
·
American Heart Journal
·
2
Show more works
View as search
Works count:
31
Citation count:
3,323
H-index:
19
I10-index:
19
Year
Topic
Type
